Tumor volume: A basic and specific response predictor in radiotherapy

Radiotherapy and Oncology

Volumn 47, Issue 2, 1998, Pages 167-174

  Dubben, Hans Hermann ^a   Thames, Howard D ^b   Beck Bornholdt, Hans Peter ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Predictive assay; Radiotherapy; Statistical power; Tumor volume

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CLINICAL EXAMINATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR VOLUME;

ANIMALS; BREAST NEOPLASMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MELANOMA; NEOPLASM TRANSPLANTATION; NEOPLASMS; PROGNOSIS; RATS; RHABDOMYOSARCOMA; TRANSPLANTATION, ISOGENEIC; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031858774     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)00215-6     Document Type: Article

References (29)

1. Arriagada, R., Mouriesse, H., Sarrazin, D., Clark, R.M. and Deboer, G. Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. Int. J. Radiat. Oncol. Biol. Phys. 11: 1751-1757, 1985.
2. Beck-Bornholdt, H.-P., Maurer, T., Becker, S., Omniczynski, M., Vogler, H. and Würschmidt, F. Radiotherapy of the rhabdomyosarcoma R1H of the rat: Hyperfractionation - 126 fractions applied within 6 weeks. Int. J. Radiat. Oncol. Biol. Phys. 16: 701-705, 1989.
3. Bentzen, S.M. and Thames, H.D. Tumor volume and local control probability: clinical data and radiobiological interpretations. Int. J. Radiat. Oncol. Biol. Phys. 36: 247-251, 1996.
4. Bentzen, S.M. Steepness of the clinical dose-response curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma. Int. J. Radiat. Biol. 20: 417-423, 1992.
5. Bentzen, S.M., Overgaard, J., Thames, H.D., Overgaard, M., Vejby Hansen, P., von der Maase, H. and Meder, J. Clinical radiobiology of malignant melanoma. Radiother. Oncol. 16: 169-182, 1989.
6. Brenner, D.J. Dose, volume, and tumor-control predictions in radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 26: 171-179, 1993.
7. Carl, J., Andersen, L.J., Pedersen, M. and Greisen, O. Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx. Radiother. Oncol. 39: 229-233, 1996.
8. Eifel, P.J., Morris, M., Taylor Wharton, J. and Oswald, M.J. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int. J. Radiat. Oncol. Biol. Phys. 29: 9-16, 1994.
9. Freeman, D.E., Mancuso, A.A., Parsons, J.T., Mendenhall, W.M. and Million, R.R. Irradiation alone for supraglottic larynx carcinoma: can CT findings predict treatment results? Int. J. Radiat. Oncol. Biol. Phys. 19: 485-490, 1990.
10. Goitein, M. and Schultheiss, T.E. Strategies for treating possible tumor extension: some theoretical considerations. Int. J. Radiat. Oncol. Biol. Phys. 11: 1519-1528, 1985.
11. pot) be compared between laboratories? A quality control study. Cytometry 19: 154-163, 1995.
12. pot as a predictive test for treatment outcome. Radiother. Oncol. 40 (Suppl. 1): S29, 1996.
13. Hjelm-Hansen, M., Jörgensen, K., Andersen, A.P. and Lund, C. Laryngeal carcinoma II. Analysis of treatment results using the Ellis model. Acta Radiol. Oncol. Radiat. Phys. Biol. 18: 385-407, 1979.
14. Ito, H., Kutuki, S., Nishiguchi, I., Shigematsu, N., Kuribayashi, T., Uematsu, M., Nakayama, T., Ka, W.J., Takemasa, K., Ando, Y. and Kubo, A. Radiotherapy for cervical cancer with high dose rate brachytherapy - correlation between tumor size, dose and failure. Radiother. Oncol. 31: 240-247, 1994.
15. Johnson, C.R., Thames, H.D., Huang, D.T. and Schmidt-Ullrich, R.K. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int. J. Radiat. Oncol. Biol. Phys. 33: 281-287, 1995.
16. Johnson, C.R., Khandelwal, S.R., Schmidt-Ullrich, R.K., Ravalese III, J. and Wazer, D.E. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation. Int. J. Radiat. Oncol. Biol. Phys. 32: 635-641, 1995.
17. Jung, H., Krüger, H.J., Brammer, I., Zywietz, F. and Beck-Bornholdt, H.-P. Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single doses of X-rays. Int. J. Radiat. Biol. 57: 567-589, 1990.
18. Magee, B.J., Logue, J.P., Swindell, R. and McHugh, D. Tumor size as a prognostic factor in carcinoma of the cervix: assessment by transrectal ultrasound. Br. J. Radiol. 64 (765): 812-815, 1991.
19. Mendenhall, W.M., Sombeck, M.D., Freeman, D.E. and Morgan, L.S. Stage IB and IIA-B carcinoma of the intact uterine cervix: impact of tumor volume and the role of adjuvant hysterectomy. Semin. Radiat. Oncol. 4: 16-22, 1994.
20. Oehler, W. Prognoseindikatoren beim inoperablen Bronchialkarzinom unter besonderer Berücksichtigung des Primärtumorvolumens. Habilitationschrift, Medizinische Fakultät Carl Gustav Carus der Technische Universität Dresden, Dresden, 1997 (submitted).
21. Overgaard, J., Overgaard, M., Vejby Hansen, P. and Von der Maase, H. Some factors of importance in the radiation treatment of malignant melanoma. Radiother. Oncol. 5: 183-192, 1986.
22. Pameijer, F.A., Mancuso, A.A., Mendenhall, W.M., Parsons, J.T. and Kubilis, P.S. Can pretreatment computed tomography predict local control in T3 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy? Int. J. Radiat. Oncol. Biol. Phys. 37: 1011-1021, 1997.
23. Raaphorst, G.P. Prediction of radiotherapy response using SF2: is it methodology or mythology? Radiother. Oncol. 28: 187-188, 1993.
24. Taylor, J.M.G., Mendenhall, W.M. and Lavey, R.S. Time-dose factors in positive neck nodes treated with irradiation only. Radiother. Oncol. 22: 167-173, 1991.
25. Thames, H.D. Bedeutung des Tumorvolumens bei der kurativen Strahlentherapie. In: Experimentelle Strahlentherapie und klinische Strahlenbiologie, Vol. 6, pp. 143-146. Editors: M. Baumann and H.-P. Beck-Bornholdt. Baumann & Beck-Bornholdt, Hamburg, 1997, ISSN 1432-864X.
26. Thames, H.D., Peters, L.J. and Ang, K.K. Accelerated fractionation. In: Current Topics in Clinical Radiobiology of Tumors, pp. 1-10. Editor: H.-P. Beck-Bornholdt. Springer Verlag, Berlin, 1993, ISBN 3-540-56512-4.
27. pot in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int. J. Radiat. Oncol. Biol. Phys. 32: 1319-1329, 1995.
28. Van den Bogaert, W., Van der Schueren, E., Horiot, J.C., De Vilhena, M., Schraub, S., Svoboda, V., Arcangeli, G., de Pauw, M. and Van Glabbeke, M. The EORTC trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors. Radiother. Oncol. 35: 100-106, 1995.
29. Würschmidt, F., Vogler, H. and Beck-Bornholdt, H.-P. Radiotherapy of the rhabdomyosarcoma R1H of the rat: the influence of the number of fractions on tumor and skin response. Int. J. Radiat. Oncol. Biol. Phys. 14: 497-502, 1988.